[
	{
		"nid": "33",
		"title": "Demo Vaccine",
		"brand_name": "Demo Vaccine",
		"company_name": "Test Company",
		"ingredient": "Demo Vaccine Ing",
		"status": "En cours d’examen",
		"date_of_approval": null,
		"language": "Français",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "33",
		"title": "Demo Vaccine",
		"brand_name": "Demo Vaccine",
		"company_name": "Test Company",
		"ingredient": "Demo Vaccine Ing",
		"status": "Under review",
		"date_of_approval": null,
		"language": "English",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "30",
		"title": "test fr",
		"brand_name": "test fr ",
		"company_name": "AstraZeneca Canada Inc",
		"ingredient": "test",
		"status": "En cours d’examen",
		"date_of_approval": null,
		"language": "Français",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "30",
		"title": "test",
		"brand_name": "test",
		"company_name": "AstraZeneca Canada Inc",
		"ingredient": "test",
		"status": "Under review",
		"date_of_approval": null,
		"language": "English",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "29",
		"title": "Casirivimab (casirivimab) et imdevimab (imdevimab)",
		"brand_name": "Casirivimab et imdevimab",
		"company_name": "Hoffmann-La Roche Limited",
		"ingredient": "casirivimab / imdevimab",
		"status": "En cours d’examen",
		"date_of_approval": null,
		"language": "Français",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "29",
		"title": "Casirivimab (casirivimab) and imdevimab (imdevimab)",
		"brand_name": "Casirivimab and imdevimab",
		"company_name": "Hoffmann-La Roche Limited",
		"ingredient": "casirivimab / imdevimab",
		"status": "Under review",
		"date_of_approval": null,
		"language": "English",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "28",
		"title": "Covishield (ChAdOx1 [recombinant])",
		"brand_name": "Covishield",
		"company_name": "Verity Pharmaceuticals Inc/Serum Institute of India",
		"ingredient": "ChAdOx1 [recombinant]",
		"status": "En cours d’examen",
		"date_of_approval": null,
		"language": "Français",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "28",
		"title": "Covishield (ChAdOx1 [recombinant])",
		"brand_name": "Covishield",
		"company_name": "Verity Pharmaceuticals Inc/Serum Institute of India",
		"ingredient": "ChAdOx1 [recombinant]",
		"status": "Under review",
		"date_of_approval": null,
		"language": "English",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "26",
		"title": "AstraZeneca COVID-19 Vaccine - Lot specific (ChAdOx1-S)",
		"brand_name": "AstraZeneca COVID-19 Vaccine - Lot specific",
		"company_name": "AstraZeneca Canada Inc",
		"ingredient": "ChAdOx1-S",
		"status": "Désigné par ordonnance provisoire (pénuries)",
		"date_of_approval": "<time datetime=\"2021-02-23T12:00:00Z\">Tue, 02/23/2021 - 12:00</time>\n",
		"language": "Français",
		"body_text": null,
		"resources": [
			{
				"id": "73",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-02-19T12:00:00Z\">Fri, 02/19/2021 - 12:00</time>\n",
				"description": "<p>Drugs included on this list are called \"designated drugs\" and are eligible for the exceptional importation and sale provisions provided for in the Interim Order. The list, which will be updated as required, is incorporated by reference in the IO and is maintained by Health Canada.</p>\n",
				"resource_link": "<a href=\"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/covid19-interim-order-drugs-medical-devices-special-foods/information-provisions-related-drugs-biocides/list.html\">Drug Shortages</a>",
				"various_dates": "No"
			},
			{
				"id": "74",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"description": "<p>Les communications des risques liés aux produits de santé sont publiées pour informer les professionnels de la santé des problèmes pouvant inclure l’innocuité ou l'efficacité d'un produit. Il s'agit d'une lettre émise par le détenteur d'une autorisation de mise sur le marché dont le contenu est approuvé par Santé Canada. La communication la plus récente se trouve ici. Toutes les CRPSs sont affichées dans la base de données des rappels et des alertes de sécurité de Santé Canada et peuvent être consultées en cliquant sur la section \" Avis \".</p>\n",
				"resource_link": "<span>Communications des risques liés aux produits de santé</span>",
				"various_dates": "No"
			},
			{
				"id": "75",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals",
					"Researchers"
				],
				"description": "<p>Les données sur les effets secondaires suivant l’immunisation. Un effet secondaire est un incident médical qui peut suivre l’immunisation. La cause n’est pas nécessairement liée au vaccin.</p>\n",
				"resource_link": "<a href=\"https://sante-infobase.canada.ca/covid-19/securite-vaccins/\">Effets secondaires suivant l’immunisation</a>",
				"various_dates": "No"
			},
			{
				"id": "76",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"description": "<p>Pour les autorisations pour la COVID-19, Santé Canada peut imposer des conditions spécifiques à l’autorisation. Ceci permet à Santé Canada de continuer de recueillir de renseignements sur l'innocuité, l'efficacité et/ou la qualité du produit, tandis que des études supplémentaires se poursuivent.</p>\n",
				"resource_link": "<span>Conditions de l’autorisation</span>",
				"various_dates": "No"
			},
			{
				"id": "77",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals",
					"Researchers"
				],
				"description": "<p>Les avis sont publiés lorsque Santé Canada a des mises à jours ou d’autres renseignements importants à communiquer, tels que l’information sur les nouvelles approbations, les pénuries, les mises à jour de l'étiquette ou les risques.</p>\n\n<p>Lorsque vous cliquez sur le lien, vous extrairez tout avis émis par Santé Canada sur le produit. Si aucun avis n’a été émis, aucun résultat ne paraîtra.</p>\n",
				"resource_link": "<a href=\"https://healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/result-resultat/fr?search_text_1=%22AstraZeneca%20COVID-19%20Vaccine%22%20OU%20%22ChAdOx1-S%22\">Avis</a>",
				"various_dates": "Yes"
			},
			{
				"id": "78",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals"
				],
				"description": "<p>Informations destinées aux professionnels de la santé sur l'utilisation de seringues et d'aiguilles à faible volume mort.</p>\n",
				"resource_link": "<span>Guide d&#039;administration pour les seringues et les aiguilles à faible volume mort</span>",
				"various_dates": "No"
			}
		]
	},
	{
		"nid": "26",
		"title": "AstraZeneca COVID-19 Vaccine - Lot specific (ChAdOx1-S)",
		"brand_name": "AstraZeneca COVID-19 Vaccine - Lot specific",
		"company_name": "AstraZeneca Canada Inc",
		"ingredient": "ChAdOx1-S",
		"status": "Designated by interim order (shortages)",
		"date_of_approval": "<time datetime=\"2021-02-23T12:00:00Z\">Tue, 02/23/2021 - 12:00</time>\n",
		"language": "English",
		"body_text": null,
		"resources": [
			{
				"id": "73",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-02-19T12:00:00Z\">Fri, 02/19/2021 - 12:00</time>\n",
				"description": "<p>Drugs included on this list are called \"designated drugs\" and are eligible for the exceptional importation and sale provisions provided for in the Interim Order. The list, which will be updated as required, is incorporated by reference in the IO and is maintained by Health Canada.</p>\n",
				"resource_link": "<a href=\"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/covid19-interim-order-drugs-medical-devices-special-foods/information-provisions-related-drugs-biocides/list.html\">Drug Shortages</a>",
				"various_dates": "No"
			},
			{
				"id": "74",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-03-01T00:11:11Z\">Mon, 03/01/2021 - 00:11</time>\n",
				"description": "<p>Health Product Risk Communications are published to inform healthcare professionals about issues that can include the safety, or effectiveness, of a health product. It is a communication issued by the market authorization holder containing content approved by Health Canada. The most recent communication can be found here. All Health Product Risk Communications are posted in Health Canada’s recalls and safety alerts database and can be found by clicking on the \"Advisories\" section.</p>\n",
				"resource_link": "<span>Health Product Risk Communications</span>",
				"various_dates": "No"
			},
			{
				"id": "75",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals",
					"Researchers"
				],
				"description": "<p>Information about adverse events following immunization. An adverse event is a medical incident that may occur following immunization. The cause is not necessarily related to the vaccine.</p>\n",
				"resource_link": "<a href=\"https://health-infobase.canada.ca/covid-19/vaccine-safety/\">Adverse Events Following Immunization</a>",
				"various_dates": "No"
			},
			{
				"id": "76",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"description": "<p>For COVID-19 authorizations, Health Canada can impose specific terms and conditions on the authorization. This allows Health Canada to continue to gather information on the safety, effectiveness and/or quality of the product as more studies are completed.</p>\n",
				"resource_link": "<span>Authorization Terms &amp; Conditions</span>",
				"various_dates": "No"
			},
			{
				"id": "77",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals",
					"Researchers"
				],
				"description": "<p>Advisories are published when Health Canada has important updates or other information to share about the product, such as information on shortages, new approvals, or risks.</p>\n\n<p>Clicking the link will retrieve any advisories Health Canada has issued about the product. If no advisories have been issued, no results will be returned.</p>\n",
				"resource_link": "<a href=\"https://healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/result-resultat/en?search_text_1=%22AstraZeneca%20COVID-19%20Vaccine%22%20OR%20%22ChAdOx1-S%22\">Advisories</a>",
				"various_dates": "Yes"
			},
			{
				"id": "78",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals"
				],
				"description": "<p>The steps to AstraZeneca COVID-19 Vaccination. Your guide to proper storage, handling, and administration of the vaccine.</p>\n",
				"resource_link": "<span>Storage, handling, and administration</span>",
				"various_dates": "No"
			}
		]
	},
	{
		"nid": "25",
		"title": "New Product 1 -french mod2",
		"brand_name": "New product -french mod2",
		"company_name": "Test Company",
		"ingredient": "new ingredient2",
		"status": "En cours d’examen",
		"date_of_approval": null,
		"language": "Français",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "25",
		"title": "New Product 1- update",
		"brand_name": "New product-update",
		"company_name": "Test Company",
		"ingredient": "new ingredient",
		"status": "Under review",
		"date_of_approval": null,
		"language": "English",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "18",
		"title": "Colchicine",
		"brand_name": "Colchicine",
		"company_name": "Pendopharm Division of Pharmascience Inc",
		"ingredient": "colchicine",
		"status": "En cours d’examen",
		"date_of_approval": null,
		"language": "Français",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "18",
		"title": "Colchicine",
		"brand_name": "Colchicine",
		"company_name": "Pendopharm Division of Pharmascience Inc",
		"ingredient": "colchicine",
		"status": "Under review",
		"date_of_approval": null,
		"language": "English",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "17",
		"title": "Favipiravir (favipiravir)",
		"brand_name": "Favipiravir",
		"company_name": "Dr Reddys Laboratories Ltd",
		"ingredient": "favipiravir",
		"status": "En cours d’examen",
		"date_of_approval": null,
		"language": "Français",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "17",
		"title": "Favipiravir (favipiravir)",
		"brand_name": "Favipiravir",
		"company_name": "Dr Reddys Laboratories Ltd",
		"ingredient": "favipiravir",
		"status": "Under review",
		"date_of_approval": null,
		"language": "English",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "16",
		"title": "Vaccin contre la COVID-19 de Pfizer-Biontech (tozinaméran)",
		"brand_name": "Vaccin contre la COVID-19 de Pfizer-Biontech",
		"company_name": "BioNTech Manufacturing GmbH",
		"ingredient": "tozinaméran",
		"status": "Autorisé par arrêté d&#039;urgence",
		"date_of_approval": "<time datetime=\"2020-12-09T12:00:00Z\">Wed, 12/09/2020 - 12:00</time>\n",
		"language": "Français",
		"body_text": "<section class=\"block block-layout-builder block-field-blocknodevaccinebody clearfix\" data-block-plugin-id=\"field_block:node:vaccine:body\">\n<div class=\"field field--name-body field--type-text-with-summary field--label-hidden field--item\">\n<section class=\"block block-layout-builder block-field-blocknodevaccinebody clearfix\" data-block-plugin-id=\"field_block:node:vaccine:body\">\n<div class=\"field field--name-body field--type-text-with-summary field--label-hidden field--item\">\n<h2>Renseignements supplémentaires</h2>\n\n<ul>\n\t<li><a href=\"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/vaccins/pfizer-biontech.html\">Ce que vous devriez savoir</a></li>\n\t<li><a href=\"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/vaccins/pfizer-biontech/autorisation.html\">Informations relatives à l'autorisation</a></li>\n\t<li><a href=\"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/vaccins/pfizer-biontech/surveillance.html\">Surveillance continue</a></li>\n</ul>\n</div>\n</section>\n</div>\n</section>\n",
		"resources": [
			{
				"id": "27",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-12-09T12:00:00Z\">Wed, 12/09/2020 - 12:00</time>\n",
				"description": "<p>Renseignements sur le produit y compris pour quoi on s’en sert, la posologie, les mises en garde, l’usage correct et les effets secondaires. Ce sommaire ne comportera pas toute l’information pertinente sur le produit. Veuillez contacter votre professionnel de la santé pour toute question sur le produit.</p>\n",
				"resource_link": "<a href=\"/info/vaccin-contre-la-covid-19-de-pfizer-biontech.html\">Renseignements à l&#039;intention des consommateurs</a>",
				"various_dates": "No"
			},
			{
				"id": "28",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-09T12:00:00Z\">Wed, 12/09/2020 - 12:00</time>\n",
				"description": "<p>La monographie de produit est un document scientifique qui décrit les propriétés, les affirmations, les indications et les conditions d'utilisation du produit, et qui contient tout autre renseignement pouvant être requis pour l’utilisation optimale, sécuritaire et efficace.</p>\n\n<p>Une monographie de produit comporte trois parties :</p>\n\n<ul>\n\t<li>\n\t<p>Partie I : Renseignements pour le professionnel de la santé</p>\n\t</li>\n\t<li>\n\t<p>Partie II : Renseignements scientifiques</p>\n\t</li>\n\t<li>\n\t<p>Renseignements sur le médicament pour le patient</p>\n\t</li>\n</ul>\n",
				"resource_link": "<a href=\"/info/pdf/vaccin-contre-la-covid-19-de-pfizer-biontech-pm1.pdf\">Monographie de produit</a>",
				"various_dates": "No"
			},
			{
				"id": "40",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2021-02-12T12:00:00Z\">Fri, 02/12/2021 - 12:00</time>\n",
				"description": "<p>Étiquettes unilingues anglaises de la fiole et de la boîte du vaccin contre la COVID-19 de Pfizer-BioNTech.</p>\n",
				"resource_link": "<a href=\"/info/pdf/vaccin-contre-la-covid-19-de-pfizer-biontech-etiquette.pdf\">Étiquette du produit</a>",
				"various_dates": "No"
			},
			{
				"id": "29",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers"
				],
				"date": "<time datetime=\"2020-12-09T12:00:00Z\">Wed, 12/09/2020 - 12:00</time>\n",
				"description": "<p>Le sommaire de décision réglementaire explique la décision de Santé Canada face au produit pour lequel une autorisation de mise en marché est demandée. Le sommaire de décision réglementaire comporte le but de la présentation et le motif de la décision.</p>\n",
				"resource_link": "<a href=\"/info/sommaire-decision-reglementaire-detailTwo.html?linkID=RDS00730\">Sommaire de décision réglementaire</a>",
				"various_dates": "No"
			},
			{
				"id": "30",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-02-09T12:00:00Z\">Tue, 02/09/2021 - 12:00</time>\n",
				"description": "<p><span lang=\"FR-CA\" style=\"mso-ansi-language:FR-CA\" xml:lang=\"FR-CA\" xml:lang=\"FR-CA\">Le sommaire des motifs de décision explique les raisons pour lesquelles un produit a reçu une autorisation de vente au Canada. Le document comprend les considérations portant sur la réglementation, l’innocuité, l’efficacité et la qualité (sur le plan de la chimie et de la fabrication).</span></p>\n",
				"resource_link": "<a href=\"/info/sommaire-motif-decision-detailTwo.html?linkID=SBD00510\">Sommaire des motifs de décision</a>",
				"various_dates": "No"
			},
			{
				"id": "70",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-02-05T12:00:00Z\">Fri, 02/05/2021 - 12:00</time>\n",
				"description": "<p>Le tableau des activités postautorisation comprend de brefs résumés des activités qui ont lieu après l'approbation du produit. Il est mis à jour chaque mois.</p>\n",
				"resource_link": "<a href=\"/info/tableau-activites-postautorisation.html?linkID=SBD00510\">Tableau des activités postautorisation (TAPA)</a>",
				"various_dates": "No"
			},
			{
				"id": "37",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-12T12:00:00Z\">Sat, 12/12/2020 - 12:00</time>\n",
				"description": "<p>Les communications des risques liés aux produits de santé sont publiées pour informer les professionnels de la santé des problèmes pouvant inclure l’innocuité ou l'efficacité d'un produit. Il s'agit d'une lettre émise par le détenteur d'une autorisation de mise sur le marché dont le contenu est approuvé par Santé Canada. Toutes les CRPSs sont affichées dans la base de données des rappels et des alertes de sécurité de Santé Canada.</p>\n",
				"resource_link": "<a href=\"/info/pdf/vaccin-contre-la-covid-19-de-pfizer-biontech-lettre.pdf\">Communications des risques liés aux produits de santé</a>",
				"various_dates": "No"
			},
			{
				"id": "67",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals",
					"Researchers"
				],
				"description": "<p>Les données sur les effets secondaires suivant l’immunisation. Un effet secondaire est un incident médical qui peut suivre l’immunisation. La cause n’est pas nécessairement liée au vaccin.</p>\n",
				"resource_link": "<a href=\"https://sante-infobase.canada.ca/covid-19/securite-vaccins/\">Effets secondaires suivant l’immunisation</a>",
				"various_dates": "Yes"
			},
			{
				"id": "35",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-03-31T12:00:00Z\">Wed, 03/31/2021 - 12:00</time>\n",
				"description": "<p>Le plan de gestion des risques de la compagnie comporte :</p>\n\n<ul>\n\t<li>Les risques connus et potentiels</li>\n\t<li>Le plan de surveillance de la compagnie, y compris le recueil des renseignements supplémentaires sur l’innocuité et l’efficacité</li>\n\t<li>Toute mesure de la part de la compagnie pour atténuer les risques associés au produit</li>\n</ul>\n\n<p>Sera publiée avant le 31 mars 2021.</p>\n",
				"resource_link": "<span>Plan de gestion des risques</span>",
				"various_dates": "No"
			},
			{
				"id": "31",
				"bundle": "vaccine_resources",
				"audience": [
					"Researchers"
				],
				"date": "<time datetime=\"2021-03-31T12:00:00Z\">Wed, 03/31/2021 - 12:00</time>\n",
				"description": "<p>Suite à l’achèvement de l’examen réglementaire, les renseignements cliniques déposés dans le cadre de la présentation sont rendus accessibles au public pour des fins non commerciales.</p>\n\n<p>Sera publiée avant le 31 mars 2021.</p>\n",
				"resource_link": "<span>Renseignements cliniques</span>",
				"various_dates": "No"
			},
			{
				"id": "32",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-09T12:00:00Z\">Wed, 12/09/2020 - 12:00</time>\n",
				"description": "<p>Pour les autorisations pour la COVID-19, Santé Canada peut imposer des conditions spécifiques à l’autorisation. Ceci permet à Santé Canada de continuer de recueillir de renseignements sur l'innocuité, l'efficacité et/ou la qualité du produit, tandis que des études supplémentaires se poursuivent.</p>\n",
				"resource_link": "<a href=\"/info/pdf/vaccin-contre-la-covid-19-de-pfizer-biontech-autorisation.pdf\">Conditions de l’autorisation</a>",
				"various_dates": "No"
			},
			{
				"id": "33",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"description": "<p>Les avis sont publiés lorsque Santé Canada a des mises à jours ou d’autres renseignements importants à communiquer, tels que l’information sur les nouvelles approbations, les pénuries, les mises à jour de l'étiquette ou les risques.</p>\n\n<p>Lorsque vous cliquez sur le lien, vous extrairez tout avis émis par Santé Canada sur le produit. Si aucun avis n’a été émis, aucun résultat ne paraîtra.</p>\n\n<p> </p>\n",
				"resource_link": "<a href=\"https://healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/result-resultat/fr?search_text_1=%22Pfizer-BioNTech%20COVID-19%20Vaccine%22%20OU%20%22tozinameran%22\">Avis</a>",
				"various_dates": "No"
			},
			{
				"id": "38",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-12-11T12:00:00Z\">Fri, 12/11/2020 - 12:00</time>\n",
				"description": "<p>Les étapes de l’administration du vaccin contre la COVID-19 de Pfizer-BioNTech. Votre guide pour assurer la conservation, la manipulation et l’administration adéquate du vaccin contre la COVID-19 de Pfizer-BioNTech.</p>\n",
				"resource_link": "<a href=\"/info/pdf/vaccin-contre-la-covid-19-de-pfizer-biontech-etapes-administration.pdf\">Conservation, manipulation et administration</a>",
				"various_dates": "No"
			},
			{
				"id": "39",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-12-11T12:00:00Z\">Fri, 12/11/2020 - 12:00</time>\n",
				"description": "<p>Directives d’expédition et de manipulation. Pour vous assurer que les contrôles appropriés sont mis en place, veuillez consulter la fiche des données de sécurité de la glace sèche avant d’accéder au contenu du conteneur d’expédition isotherme, et consultez votre service de santé et sécurité au travail.</p>\n",
				"resource_link": "<a href=\"/info/pdf/vaccin-contre-la-covid-19-de-pfizer-biontech-directives-expedition-manipulation.pdf\">Directives d’expédition et de manipulation</a>",
				"various_dates": "No"
			}
		]
	},
	{
		"nid": "15",
		"title": "Vaccin de Moderna contre la COVID-19 (ARNm-1273 SRAS-CoV-2)",
		"brand_name": "Vaccin de Moderna contre la COVID-19",
		"company_name": "Moderna Therapeutics Inc",
		"ingredient": "ARNm-1273 SRAS-CoV-2",
		"status": "Autorisé par arrêté d&#039;urgence",
		"date_of_approval": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
		"language": "Français",
		"body_text": "<section class=\"block block-layout-builder block-field-blocknodevaccinebody clearfix\" data-block-plugin-id=\"field_block:node:vaccine:body\">\n<div class=\"field field--name-body field--type-text-with-summary field--label-hidden field--item\">\n<section class=\"block block-layout-builder block-field-blocknodevaccinebody clearfix\" data-block-plugin-id=\"field_block:node:vaccine:body\">\n<div class=\"field field--name-body field--type-text-with-summary field--label-hidden field--item\">\n<h2>Renseignements supplémentaires</h2>\n\n<ul>\n\t<li><a href=\"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/vaccins/moderna.html\">Ce que vous devriez savoir</a></li>\n\t<li><a href=\"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/vaccins/moderna/autorisation.html\">Informations relatives à l'autorisation</a></li>\n\t<li><a href=\"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/vaccins/moderna/surveillance.html\">Surveillance continue</a></li>\n</ul>\n</div>\n</section>\n</div>\n</section>\n",
		"resources": [
			{
				"id": "53",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>Renseignements sur le produit y compris pour quoi on s’en sert, la posologie, les mises en garde, l’usage correct et les effets secondaires. Ce sommaire ne comportera pas toute l’information pertinente sur le produit. Veuillez contacter votre professionnel de la santé pour toute question sur le produit.</p>\n",
				"resource_link": "<a href=\"/info/vaccin-de-moderna-contre-la-covid-19.html\">Renseignements à l&#039;intention des consommateurs</a>",
				"various_dates": "No"
			},
			{
				"id": "54",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>La monographie de produit est un document scientifique qui décrit les propriétés, les affirmations, les indications et les conditions d'utilisation du produit, et qui contient tout autre renseignement pouvant être requis pour l’utilisation optimale, sécuritaire et efficace.</p>\n\n<p>Une monographie de produit comporte trois parties :</p>\n\n<ul>\n\t<li>Partie I : Renseignements pour le professionnel de la santé</li>\n\t<li>Partie II : Renseignements scientifiques</li>\n\t<li>Renseignements sur le médicament pour le patient</li>\n</ul>\n",
				"resource_link": "<a href=\"/info/pdf/vaccin-de-moderna-contre-la-covid-19-pm1.pdf\">Monographie de produit</a>",
				"various_dates": "No"
			},
			{
				"id": "55",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>Étiquettes unilingues anglaises de la fiole et de la boîte du vaccin de Moderna contre la COVID-19.</p>\n",
				"resource_link": "<a href=\"/info/pdf/vaccin-de-moderna-contre-la-covid-19-etiquette.pdf\">Étiquette du produit</a>",
				"various_dates": "No"
			},
			{
				"id": "56",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>Le sommaire de décision réglementaire explique la décision de Santé Canada face au produit pour lequel une autorisation de mise en marché est demandée. Le sommaire de décision réglementaire comporte le but de la présentation et le motif de la décision.</p>\n",
				"resource_link": "<a href=\"/info/sommaire-decision-reglementaire-detailTwo.html?linkID=RDS00736\">Sommaire de décision réglementaire</a>",
				"various_dates": "No"
			},
			{
				"id": "57",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-01-06T12:00:00Z\">Wed, 01/06/2021 - 12:00</time>\n",
				"description": "<p>Le sommaire des motifs de décision explique les raisons pour lesquelles un produit a reçu une autorisation de vente au Canada. Le document comprend les considérations portant sur la réglementation, l’innocuité, l’efficacité et la qualité (sur le plan de la chimie et de la fabrication).</p>\n",
				"resource_link": "<a href=\"/info/sommaire-motif-decision-detailTwo.html?linkID=SBD00511\">Sommaire des motifs de décision</a>",
				"various_dates": "No"
			},
			{
				"id": "69",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-01-06T13:00:00Z\">Wed, 01/06/2021 - 13:00</time>\n",
				"description": "<p>Le tableau des activités postautorisation comprend de brefs résumés des activités qui ont lieu après l'approbation du produit. Il est mis à jour chaque mois.</p>\n",
				"resource_link": "<a href=\"/info/tableau-activites-postautorisation.html?linkID=SBD00511\">Tableau des activités postautorisation (TAPA)</a>",
				"various_dates": "No"
			},
			{
				"id": "58",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>Les communications des risques liés aux produits de santé sont publiées pour informer les professionnels de la santé des problèmes pouvant inclure l’innocuité ou l'efficacité d'un produit. Il s'agit d'une lettre émise par le détenteur d'une autorisation de mise sur le marché dont le contenu est approuvé par Santé Canada. Toutes les CRPSs sont affichées dans la base de données des rappels et des alertes de sécurité de Santé Canada.</p>\n",
				"resource_link": "<a href=\"/info/pdf/vaccin-de-moderna-contre-la-covid-19-lettre-20201223.pdf\">Communications des risques liés aux produits de santé</a>",
				"various_dates": "No"
			},
			{
				"id": "66",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals",
					"Researchers"
				],
				"description": "<p>Les données sur les effets secondaires suivant l’immunisation. Un effet secondaire est un incident médical qui peut suivre l’immunisation. La cause n’est pas nécessairement liée au vaccin.</p>\n",
				"resource_link": "<span>Effets secondaires suivant l’immunisation</span>",
				"various_dates": "No"
			},
			{
				"id": "59",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-03-31T12:00:00Z\">Wed, 03/31/2021 - 12:00</time>\n",
				"description": "<p>Le plan de gestion des risques de la compagnie comporte :</p>\n\n<ul>\n\t<li>Les risques connus et potentiels</li>\n\t<li>Le plan de surveillance de la compagnie, y compris le recueil des renseignements supplémentaires sur l’innocuité et l’efficacité</li>\n\t<li>Toute mesure de la part de la compagnie pour atténuer les risques associés au produit</li>\n</ul>\n\n<p>Sera publiée avant le 31 mars 2021.</p>\n",
				"resource_link": "<span>Plan de gestion des risques</span>",
				"various_dates": "No"
			},
			{
				"id": "60",
				"bundle": "vaccine_resources",
				"audience": [
					"Researchers"
				],
				"date": "<time datetime=\"2021-03-31T12:00:00Z\">Wed, 03/31/2021 - 12:00</time>\n",
				"description": "<p>Suite à l’achèvement de l’examen réglementaire, les renseignements cliniques déposés dans le cadre de la présentation sont rendus accessibles au public pour des fins non commerciales.</p>\n\n<p>Sera publiée avant le 31 mars 2021.</p>\n",
				"resource_link": "<span>Renseignements cliniques</span>",
				"various_dates": "No"
			},
			{
				"id": "61",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>Pour les autorisations pour la COVID-19, Santé Canada peut imposer des conditions spécifiques à l’autorisation. Ceci permet à Santé Canada de continuer de recueillir de renseignements sur l'innocuité, l'efficacité et/ou la qualité du produit, tandis que des études supplémentaires se poursuivent.</p>\n",
				"resource_link": "<a href=\"/info/pdf/vaccin-de-moderna-contre-la-covid-19-autorisation.pdf\">Conditions de l’autorisation</a>",
				"various_dates": "No"
			},
			{
				"id": "62",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"description": "<p>Les avis sont publiés lorsque Santé Canada a des mises à jours ou d’autres renseignements importants à communiquer, tels que l’information sur les nouvelles approbations, les pénuries, les mises à jour de l'étiquette ou les risques.</p>\n\n<p>Lorsque vous cliquez sur le lien, vous extrairez tout avis émis par Santé Canada sur le produit. Si aucun avis n’a été émis, aucun résultat ne paraîtra.</p>\n",
				"resource_link": "<a href=\"https://healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/result-resultat/fr?search_text_1=%22Vaccin%20de%20Moderna%20contre%20la%20COVID-19%22%20OU%20%22ARNm-1273%20SRAS-CoV-2%22\">Avis</a>",
				"various_dates": "Yes"
			},
			{
				"id": "63",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>Les étapes de l’administration du vaccin de Moderna contre la COVID-19. Votre guide pour assurer la conservation, la manipulation et l’administration adéquate du vaccin de Moderna contre la COVID-19.</p>\n",
				"resource_link": "<a href=\"/info/pdf/vaccin-de-moderna-contre-la-covid-19-entreposage-manipulation.pdf\">Conservation, manipulation et administration</a>",
				"various_dates": "No"
			}
		]
	},
	{
		"nid": "14",
		"title": "JNJ-78436735/Ad26.COV2.S",
		"brand_name": "JNJ-78436735/Ad26.COV2.S",
		"company_name": "Janssen Inc",
		"ingredient": "Ad26.COV2.S",
		"status": "En cours d’examen",
		"date_of_approval": null,
		"language": "Français",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "13",
		"title": "Vaccin d’AstraZeneca contre la COVID-19 (ChAdOx1-S)",
		"brand_name": "Vaccin d’AstraZeneca contre la COVID-19",
		"company_name": "AstraZeneca Canada Inc",
		"ingredient": "ChAdOx1-S",
		"status": "En cours d’examen",
		"date_of_approval": null,
		"language": "Français",
		"body_text": null,
		"resources": [
			{
				"id": "79",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals",
					"Researchers"
				],
				"description": "<p>TBD</p>\n",
				"resource_link": "<span>test</span>",
				"various_dates": "No"
			}
		]
	},
	{
		"nid": "8",
		"title": "Bamlanivimab (bamlanivimab)",
		"brand_name": "Bamlanivimab",
		"company_name": "Eli Lilly Canada Inc",
		"ingredient": "bamlanivimab",
		"status": "Autorisé par arrêté d&#039;urgence",
		"date_of_approval": null,
		"language": "Français",
		"body_text": null,
		"resources": [
			{
				"id": "17",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-11-20T12:00:00Z\">Fri, 11/20/2020 - 12:00</time>\n",
				"description": "<p>Renseignements sur le produit y compris pour quoi on s’en sert, la posologie, les mises en garde, l’usage correct et les effets secondaires. Ce sommaire ne comportera pas toute l’information pertinente sur le produit. Veuillez contacter votre professionnel de la santé pour toute question sur le produit.</p>\n",
				"resource_link": "<a href=\"/info/bamlanivimab-fr.html\">Renseignements à l&#039;intention des consommateurs</a>",
				"various_dates": "No"
			},
			{
				"id": "18",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-11-20T12:00:00Z\">Fri, 11/20/2020 - 12:00</time>\n",
				"description": "<p>La monographie de produit est un document scientifique qui décrit les propriétés, les affirmations, les indications et les conditions d'utilisation du produit, et qui contient tout autre renseignement pouvant être requis pour l’utilisation optimale, sécuritaire et efficace.</p>\n\n<p>Une monographie de produit comporte trois parties :</p>\n\n<ul>\n\t<li>\n\t<p>Partie I : Renseignements pour le professionnel de la santé</p>\n\t</li>\n\t<li>\n\t<p>Partie II : Renseignements scientifiques</p>\n\t</li>\n\t<li>\n\t<p>Renseignements sur le médicament pour le patient</p>\n\t</li>\n</ul>\n\n<p> </p>\n",
				"resource_link": "<a href=\"/info/pdf/bamlanivimab-pm1-fr.pdf\">Monographie de produit</a>",
				"various_dates": "No"
			},
			{
				"id": "19",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers"
				],
				"date": "<time datetime=\"2020-10-12T12:00:00Z\">Mon, 10/12/2020 - 12:00</time>\n",
				"description": "<p>Le sommaire de décision réglementaire explique la décision de Santé Canada face au produit pour lequel une autorisation de mise en marché est demandée. Le sommaire de décision réglementaire comporte le but de la présentation et le motif de la décision.</p>\n",
				"resource_link": "<a href=\"/info/sommaire-decision-reglementaire-detailTwo.html?linkID=RDS00719\">Sommaire de décision réglementaire</a>",
				"various_dates": "No"
			},
			{
				"id": "20",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-01-08T16:00:00Z\">Fri, 01/08/2021 - 16:00</time>\n",
				"description": "<p class=\"MsoNormal\"><span lang=\"FR-CA\" style=\"mso-ansi-language:FR-CA\" xml:lang=\"FR-CA\">Le sommaire des motifs de décision explique les raisons pour lesquelles un produit a reçu une autorisation de vente au Canada. Le document comprend les considérations portant sur la réglementation, l’innocuité, l’efficacité et la qualité (sur le plan de la chimie et de la fabrication).</span></p>\n",
				"resource_link": "<a href=\"/info/sommaire-motif-decision-detailTwo.html?linkID=SBD00512\">Sommaire des motifs de décision</a>",
				"various_dates": "No"
			},
			{
				"id": "71",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-02-05T12:00:00Z\">Fri, 02/05/2021 - 12:00</time>\n",
				"description": "<p>Le tableau des activités postautorisation comprend de brefs résumés des activités qui ont lieu après l'approbation du produit. Il est mis à jour chaque mois.</p>\n",
				"resource_link": "<a href=\"/info/tableau-activites-postautorisation.html?linkID=SBD00512\">Tableau des activités postautorisation (TAPA)</a>",
				"various_dates": "No"
			},
			{
				"id": "21",
				"bundle": "vaccine_resources",
				"audience": [
					"Researchers"
				],
				"date": "<time datetime=\"2021-01-04T12:00:00Z\">Mon, 01/04/2021 - 12:00</time>\n",
				"description": "<p>Suite à l’achèvement de l’examen réglementaire, les renseignements cliniques déposés dans le cadre de la présentation sont rendus accessibles au public pour des fins non commerciales.</p>\n",
				"resource_link": "<a href=\"https://renseignements-cliniques.canada.ca/ci-rc/conditions?id=244947\">Renseignements cliniques</a>",
				"various_dates": "No"
			},
			{
				"id": "22",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-23T10:00:00Z\">Wed, 12/23/2020 - 10:00</time>\n",
				"description": "<p>Pour les autorisations pour la COVID-19, Santé Canada peut imposer des conditions spécifiques à l’autorisation. Ceci permet à Santé Canada de continuer de recueillir de renseignements sur l'innocuité, l'efficacité et/ou la qualité du produit, tandis que des études supplémentaires se poursuivent.</p>\n",
				"resource_link": "<a href=\"/info/pdf/bamlanivimab-autorisation.pdf\">Conditions de l’autorisation</a>",
				"various_dates": "No"
			},
			{
				"id": "23",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"description": "<p>Les avis sont publiés lorsque Santé Canada a des mises à jours ou d’autres renseignements importants à communiquer, tels que l’information sur les nouvelles approbations, les pénuries, les mises à jour de l'étiquette ou les risques.</p>\n\n<p>Lorsque vous cliquez sur le lien, vous extrairez tout avis émis par Santé Canada sur le produit. Si aucun avis n’a été émis, aucun résultat ne paraîtra.</p>\n\n<p> </p>\n",
				"resource_link": "<a href=\"https://healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/result-resultat/fr?search_text_1=bamlanivimab%20OU%20Bamlanivimab\">Avis</a>",
				"various_dates": "Yes"
			}
		]
	},
	{
		"nid": "9",
		"title": "Veklury (remdesivir)",
		"brand_name": "Veklury",
		"company_name": "Gilead Sciences Canada Inc",
		"ingredient": "remdesivir",
		"status": "Autorisé",
		"date_of_approval": "<time datetime=\"2020-07-27T12:00:00Z\">Mon, 07/27/2020 - 12:00</time>\n",
		"language": "Français",
		"body_text": "<h2>Renseignements supplémentaires</h2>\n\n<ul>\n\t<li><a href=\"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/traitements/remdesivir.html\">Ce que vous devriez savoir</a></li>\n\t<li><a href=\"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/traitements/remdesivir/autorisation.html\">Informations relatives à l'autorisation</a></li>\n\t<li><a href=\"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/traitements/remdesivir/surveillance.html\">Surveillance continue</a></li>\n</ul>\n",
		"resources": [
			{
				"id": "5",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-07-27T12:00:00Z\">Mon, 07/27/2020 - 12:00</time>\n",
				"description": "<p>Renseignements sur le produit y compris pour quoi on s’en sert, la posologie, les mises en garde, l’usage correct et les effets secondaires. Ce sommaire ne comportera pas toute l’information pertinente sur le produit. Veuillez contacter votre professionnel de la santé pour toute question sur le produit.</p>\n",
				"resource_link": "<a href=\"/info/veklury-fr.html\">Renseignements à l&#039;intention des consommateurs</a>",
				"various_dates": "No"
			},
			{
				"id": "6",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-07-27T12:00:00Z\">Mon, 07/27/2020 - 12:00</time>\n",
				"description": "<p>La monographie de produit est un document scientifique qui décrit les propriétés, les affirmations, les indications et les conditions d'utilisation du produit, et qui contient tout autre renseignement pouvant être requis pour l’utilisation optimale, sécuritaire et efficace.</p>\n\n<p>Une monographie de produit comporte trois parties :</p>\n\n<ul>\n\t<li>\n\t<p>Partie I : Renseignements pour le professionnel de la santé</p>\n\t</li>\n\t<li>\n\t<p>Partie II : Renseignements scientifiques</p>\n\t</li>\n\t<li>\n\t<p>Renseignements sur le médicament pour le patient</p>\n\t</li>\n</ul>\n\n<p> </p>\n",
				"resource_link": "<a href=\"/info/pdf/veklury-pm1-fr.pdf\">Monographie de produit</a>",
				"various_dates": "No"
			},
			{
				"id": "8",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers"
				],
				"date": "<time datetime=\"2020-12-02T12:00:00Z\">Wed, 12/02/2020 - 12:00</time>\n",
				"description": "<p>Le sommaire de décision réglementaire explique la décision de Santé Canada face au produit pour lequel une autorisation de mise en marché est demandée. Le sommaire de décision réglementaire comporte le but de la présentation et le motif de la décision.</p>\n",
				"resource_link": "<a href=\"/info/sommaire-decision-reglementaire-detail.html?linkID=RDS00669\">Sommaire de décision réglementaire</a>",
				"various_dates": "No"
			},
			{
				"id": "14",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-02T12:00:00Z\">Wed, 12/02/2020 - 12:00</time>\n",
				"description": "<p class=\"MsoNormal\"><span lang=\"FR-CA\" style=\"mso-ansi-language:FR-CA\" xml:lang=\"FR-CA\">Le sommaire des motifs de décision explique les raisons pour lesquelles un produit a reçu une autorisation de vente au Canada. Le document comprend les considérations portant sur la réglementation, l’innocuité, l’efficacité et la qualité (sur le plan de la chimie et de la fabrication). </span></p>\n",
				"resource_link": "<a href=\"/info/sommaire-motif-decision-detailTwo.html?linkID=SBD00491\">Sommaire des motifs de décision</a>",
				"various_dates": "No"
			},
			{
				"id": "72",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-01-26T13:00:00Z\">Tue, 01/26/2021 - 13:00</time>\n",
				"description": "<p>Le tableau des activités postautorisation comprend de brefs résumés des activités qui ont lieu après l'approbation du produit. Il est mis à jour chaque mois.</p>\n",
				"resource_link": "<a href=\"/info/tableau-activites-postautorisation.html?linkID=SBD00491\">Tableau des activités postautorisation (TAPA)</a>",
				"various_dates": "No"
			},
			{
				"id": "10",
				"bundle": "vaccine_resources",
				"audience": [
					"Researchers"
				],
				"date": "<time datetime=\"2020-10-30T12:00:00Z\">Fri, 10/30/2020 - 12:00</time>\n",
				"description": "<p>Suite à l’achèvement de l’examen réglementaire, les renseignements cliniques déposés dans le cadre de la présentation sont rendus accessibles au public pour des fins non commerciales.</p>\n",
				"resource_link": "<a href=\"https://clinical-information.canada.ca/ci-rc/terms?id=240551\">Renseignements cliniques</a>",
				"various_dates": "No"
			},
			{
				"id": "15",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-07-27T12:00:00Z\">Mon, 07/27/2020 - 12:00</time>\n",
				"description": "<p>Pour les autorisations pour la COVID-19, Santé Canada peut imposer des conditions spécifiques à l’autorisation. Ceci permet à Santé Canada de continuer de recueillir de renseignements sur l'innocuité, l'efficacité et/ou la qualité du produit, tandis que des études supplémentaires se poursuivent.</p>\n",
				"resource_link": "<a href=\"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/avis-conformite/conditions/avis-admissibilite-veklury-240551.html\">Conditions de l’autorisation</a>",
				"various_dates": "No"
			},
			{
				"id": "7",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"description": "<p>Les avis sont publiés lorsque Santé Canada a des mises à jours ou d’autres renseignements importants à communiquer, tels que l’information sur les nouvelles approbations, les pénuries, les mises à jour de l'étiquette ou les risques.</p>\n\n<p>Lorsque vous cliquez sur le lien, vous extrairez tout avis émis par Santé Canada sur le produit. Si aucun avis n’a été émis, aucun résultat ne paraîtra.</p>\n\n<p> </p>\n",
				"resource_link": "<a href=\"https://healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/result-resultat/fr?search_text_1=remdesivir%20OU%20veklury\">Avis</a>",
				"various_dates": "Yes"
			},
			{
				"id": "13",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-11-26T12:00:00Z\">Thu, 11/26/2020 - 12:00</time>\n",
				"description": "<p>Une mise à jour de Santé Canada sur la surveillance continue de l'utilisation du remdésivir pour la COVID-19.</p>\n",
				"resource_link": "<a href=\"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/mise-a-jour-remdesivir.html\">Mise à jour sur le remdésivir : surveillance continue</a>",
				"various_dates": "No"
			}
		]
	},
	{
		"nid": "16",
		"title": "Pfizer-BioNTech COVID-19 Vaccine (tozinameran)",
		"brand_name": "Pfizer-BioNTech COVID-19 Vaccine",
		"company_name": "BioNTech Manufacturing GmbH",
		"ingredient": "tozinameran",
		"status": "Authorized By Interim Order",
		"date_of_approval": "<time datetime=\"2020-12-09T12:00:00Z\">Wed, 12/09/2020 - 12:00</time>\n",
		"language": "English",
		"body_text": "<section class=\"block block-layout-builder block-field-blocknodevaccinebody clearfix\" data-block-plugin-id=\"field_block:node:vaccine:body\">\n<div class=\"field field--name-body field--type-text-with-summary field--label-hidden field--item\">\n<h2>More information</h2>\n\n<ul>\n\t<li><a href=\"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/pfizer-biontech.html\">What you should know</a></li>\n\t<li><a href=\"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/pfizer-biontech/authorization.html\">Authorization information</a></li>\n\t<li><a href=\"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/pfizer-biontech/monitoring.html\">Continued monitoring</a></li>\n</ul>\n</div>\n</section>\n",
		"resources": [
			{
				"id": "27",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-12-09T12:00:00Z\">Wed, 12/09/2020 - 12:00</time>\n",
				"description": "<p>Information about the product including what the product is used for, dosage, warnings, proper use and side effects.  This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.</p>\n",
				"resource_link": "<a href=\"/info/pfizer-biontech-covid-19-vaccine-en.html\">Consumer Information</a>",
				"various_dates": "No"
			},
			{
				"id": "28",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-09T12:00:00Z\">Wed, 12/09/2020 - 12:00</time>\n",
				"description": "<p>The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use.</p>\n\n<p>The Product Monograph includes three sections:</p>\n\n<ul>\n\t<li>Part I: Health Professional Information;</li>\n\t<li>Part II: Scientific Information; and</li>\n\t<li>Patient Medication Information</li>\n</ul>\n",
				"resource_link": "<a href=\"/info/pdf/pfizer-biontech-covid-19-vaccine-pm1-en.pdf\">Product Monograph</a>",
				"various_dates": "No"
			},
			{
				"id": "40",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-12-12T12:00:00Z\">Sat, 12/12/2020 - 12:00</time>\n",
				"description": "<p>Vial and carton labels for Pfizer-BioNTech COVID-19 Vaccine with English-only labelling.</p>\n",
				"resource_link": "<a href=\"/info/pdf/pfizer-biontech-covid-19-label.pdf\">Product Label</a>",
				"various_dates": "No"
			},
			{
				"id": "29",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers"
				],
				"date": "<time datetime=\"2020-12-09T12:00:00Z\">Wed, 12/09/2020 - 12:00</time>\n",
				"description": "<p>The Regulatory Decision Summary explains Health Canada’s decision for the product seeking market authorization. The Regulatory Decision Summary includes the purpose of the submission and the reason for the decision.</p>\n",
				"resource_link": "<a href=\"/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00730\">Regulatory Decision Summary</a>",
				"various_dates": "No"
			},
			{
				"id": "30",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-02-09T12:00:00Z\">Tue, 02/09/2021 - 12:00</time>\n",
				"description": "<p>The Summary Basis of Decision explains why the product was approved for sale in Canada. The document includes regulatory, safety, effectiveness and quality (in terms of chemistry and manufacturing) considerations.</p>\n",
				"resource_link": "<a href=\"/info/summary-basis-decision-detailTwo.html?linkID=SBD00510\">Summary Basis of Decision</a>",
				"various_dates": "No"
			},
			{
				"id": "70",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-02-05T12:00:00Z\">Fri, 02/05/2021 - 12:00</time>\n",
				"description": "<p>The Post Authorization Activity Table includes brief summaries of the activities that occur after the approval of the product. It is updated on a monthly basis.</p>\n",
				"resource_link": "<a href=\"/info/post-authorization-activity-table.html?linkID=SBD00510\">Post-Authorization Activity Table (PAAT)</a>",
				"various_dates": "No"
			},
			{
				"id": "37",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-12T12:00:00Z\">Sat, 12/12/2020 - 12:00</time>\n",
				"description": "<p>Health Product Risk Communications are published to inform healthcare professionals about issues that can include the safety, or effectiveness, of a health product. It is a communication issued by the market authorization holder containing content approved by Health Canada. All Health Product Risk Communications are posted in Health Canada’s recalls and safety alerts database.</p>\n",
				"resource_link": "<a href=\"/info/pdf/pfizer-biontech-covid-19-letter.pdf\">Health Product Risk Communications</a>",
				"various_dates": "No"
			},
			{
				"id": "67",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals",
					"Researchers"
				],
				"description": "<p>Information about adverse events following immunization. An adverse event is a medical incident that may occur following immunization. The cause is not necessarily related to the vaccine.</p>\n",
				"resource_link": "<a href=\"https://health-infobase.canada.ca/covid-19/vaccine-safety/\">Adverse Events Following Immunization</a>",
				"various_dates": "Yes"
			},
			{
				"id": "35",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-03-31T12:00:00Z\">Wed, 03/31/2021 - 12:00</time>\n",
				"description": "<p>The Company’s Risk Management Plan describes:</p>\n\n<ul>\n\t<li>Known and potential safety issues</li>\n\t<li>The company’s monitoring plan, including plans for collection of additional safety and effectiveness information</li>\n\t<li>Any measures that will be put in place to minimize risks associated with the product.</li>\n</ul>\n\n<p>To be published before March 31, 2021.</p>\n\n<p> </p>\n",
				"resource_link": "<span>Risk Management Plan</span>",
				"various_dates": "No"
			},
			{
				"id": "31",
				"bundle": "vaccine_resources",
				"audience": [
					"Researchers"
				],
				"date": "<time datetime=\"2021-03-31T12:00:00Z\">Wed, 03/31/2021 - 12:00</time>\n",
				"description": "<p>After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.</p>\n\n<p>To be published before March 31, 2021.</p>\n",
				"resource_link": "<span>Clinical Information</span>",
				"various_dates": "No"
			},
			{
				"id": "32",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-09T12:00:00Z\">Wed, 12/09/2020 - 12:00</time>\n",
				"description": "<p>For COVID-19 authorizations, Health Canada can impose specific terms and conditions on the authorization. This allows Health Canada to continue to gather information on the safety, effectiveness and/or quality of the product as more studies are completed.</p>\n",
				"resource_link": "<a href=\"/info/pdf/pfizer-biontech-covid-19-vaccine-authorisation.pdf\">Authorization Terms &amp; Conditions</a>",
				"various_dates": "No"
			},
			{
				"id": "33",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"description": "<p>Advisories are published when Health Canada has important updates or other information to share about the product, such as information on shortages, new approvals, or risks.</p>\n\n<p>Clicking the link will retrieve any advisories Health Canada has issued about the product. If no advisories have been issued, no results will be returned.</p>\n",
				"resource_link": "<a href=\"https://healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/result-resultat/en?search_text_1=%22Pfizer-BioNTech%20COVID-19%20Vaccine%22%20OR%20%22tozinameran%22\">Advisories</a>",
				"various_dates": "Yes"
			},
			{
				"id": "38",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-12-11T12:00:00Z\">Fri, 12/11/2020 - 12:00</time>\n",
				"description": "<p>The steps to Pfizer-BioNTech COVID-19 Vaccination. Your guide to proper storage, handling, and administration for the Pfizer-BioNTech COVID-19 Vaccine.</p>\n",
				"resource_link": "<a href=\"/info/pdf/pfizer-biontech-covid-19-steps-leaflet-en.pdf\">Storage, handling, and administration</a>",
				"various_dates": "No"
			},
			{
				"id": "39",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-12-11T12:00:00Z\">Fri, 12/11/2020 - 12:00</time>\n",
				"description": "<p>Shipping and handling guidelines. To ensure appropriate controls are in place, review the enclosed dry ice safety data sheet before accessing the contents from the thermal shipping container and consult with your occupational health department.</p>\n",
				"resource_link": "<a href=\"/info/pdf/pfizer-biontech-covid-19-shipping-handling-guidelines-en.pdf\">Shipping and handling guidelines</a>",
				"various_dates": "No"
			}
		]
	},
	{
		"nid": "15",
		"title": "Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2)",
		"brand_name": "Moderna COVID-19 Vaccine",
		"company_name": "Moderna Therapeutics Inc",
		"ingredient": "mRNA-1273 SARS-CoV-2",
		"status": "Authorized By Interim Order",
		"date_of_approval": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
		"language": "English",
		"body_text": "<section class=\"block block-layout-builder block-field-blocknodevaccinebody clearfix\" data-block-plugin-id=\"field_block:node:vaccine:body\">\n<div class=\"field field--name-body field--type-text-with-summary field--label-hidden field--item\">\n<h2>More information</h2>\n\n<ul>\n\t<li><a href=\"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/moderna.html\">What you should know</a></li>\n\t<li><a href=\"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/moderna/authorization.html\">Authorization information</a></li>\n\t<li><a href=\"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/moderna/monitoring.html\">Continued monitoring</a></li>\n</ul>\n</div>\n</section>\n",
		"resources": [
			{
				"id": "53",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>Information about the product including what the product is used for, dosage, warnings, proper use and side effects.  This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.</p>\n",
				"resource_link": "<a href=\"/info/moderna-covid-19-vaccine.html\">Consumer Information</a>",
				"various_dates": "No"
			},
			{
				"id": "54",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use.</p>\n\n<p>The Product Monograph includes three sections:</p>\n\n<ul>\n\t<li>Part I: Health Professional Information;</li>\n\t<li>Part II: Scientific Information; and</li>\n\t<li>Patient Medication Information</li>\n</ul>\n\n<p> </p>\n",
				"resource_link": "<a href=\"/info/pdf/moderna-covid-19-vaccine-pm1.pdf\">Product Monograph</a>",
				"various_dates": "No"
			},
			{
				"id": "55",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>Vial and carton labels for Moderna COVID-19 Vaccine with English-only labelling.</p>\n",
				"resource_link": "<a href=\"/info/pdf/moderna-covid-19-vaccine-label.pdf\">Product Label</a>",
				"various_dates": "No"
			},
			{
				"id": "56",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>The Regulatory Decision Summary explains Health Canada’s decision for the product seeking market authorization. The Regulatory Decision Summary includes the purpose of the submission and the reason for the decision.</p>\n",
				"resource_link": "<a href=\"/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00736\">Regulatory Decision Summary</a>",
				"various_dates": "No"
			},
			{
				"id": "57",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-01-06T12:00:00Z\">Wed, 01/06/2021 - 12:00</time>\n",
				"description": "<p>The Summary Basis of Decision explains why the product was approved for sale in Canada. The document includes regulatory, safety, effectiveness and quality (in terms of chemistry and manufacturing) considerations.</p>\n",
				"resource_link": "<a href=\"/info/summary-basis-decision-detailTwo.html?linkID=SBD00511\">Summary Basis of Decision</a>",
				"various_dates": "No"
			},
			{
				"id": "69",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-01-06T13:00:00Z\">Wed, 01/06/2021 - 13:00</time>\n",
				"description": "<p>The Post Authorization Activity Table includes brief summaries of the activities that occur after the approval of the product. It is updated on a monthly basis.</p>\n",
				"resource_link": "<a href=\"/info/post-authorization-activity-table.html?linkID=SBD00511\">Post-Authorization Activity Table (PAAT) </a>",
				"various_dates": "No"
			},
			{
				"id": "58",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>Health Product Risk Communications are published to inform healthcare professionals about issues that can include the safety, or effectiveness, of a health product. It is a communication issued by the market authorization holder containing content approved by Health Canada. All Health Product Risk Communications are posted in Health Canada’s recalls and safety alerts database.</p>\n\n<p> </p>\n",
				"resource_link": "<a href=\"/info/pdf/moderna-covid-19-vaccine-letter-20201223.pdf\">Health Product Risk Communications</a>",
				"various_dates": "No"
			},
			{
				"id": "66",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals",
					"Researchers"
				],
				"description": "<p>Information about adverse events following immunization. An adverse event is a medical incident that may occur following immunization. The cause is not necessarily related to the vaccine.</p>\n",
				"resource_link": "<span>Adverse Events Following Immunization</span>",
				"various_dates": "No"
			},
			{
				"id": "59",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-03-31T12:00:00Z\">Wed, 03/31/2021 - 12:00</time>\n",
				"description": "<p>The Company’s Risk Management Plan describes:</p>\n\n<ul>\n\t<li>Known and potential safety issues</li>\n\t<li>The company’s monitoring plan, including plans for collection of additional safety and effectiveness information</li>\n\t<li>Any measures that will be put in place to minimize risks associated with the product.</li>\n</ul>\n\n<p>To be published before March 31, 2021.</p>\n",
				"resource_link": "<span>Risk Management Plan</span>",
				"various_dates": "No"
			},
			{
				"id": "60",
				"bundle": "vaccine_resources",
				"audience": [
					"Researchers"
				],
				"date": "<time datetime=\"2021-03-31T12:00:00Z\">Wed, 03/31/2021 - 12:00</time>\n",
				"description": "<p>After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.</p>\n\n<p>To be published before March 31, 2021.</p>\n",
				"resource_link": "<span>Clinical Information</span>",
				"various_dates": "No"
			},
			{
				"id": "61",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>For COVID-19 authorizations, Health Canada can impose specific terms and conditions on the authorization. This allows Health Canada to continue to gather information on the safety, effectiveness and/or quality of the product as more studies are completed.</p>\n",
				"resource_link": "<a href=\"/info/pdf/moderna-covid-19-vaccine-authorisation.pdf\">Authorization Terms &amp; Conditions</a>",
				"various_dates": "No"
			},
			{
				"id": "62",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"description": "<p>Advisories are published when Health Canada has important updates or other information to share about the product, such as information on shortages, new approvals, or risks.</p>\n\n<p>Clicking the link will retrieve any advisories Health Canada has issued about the product. If no advisories have been issued, no results will be returned.</p>\n",
				"resource_link": "<a href=\"https://healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/result-resultat/en?search_text_1=%22Moderna%20COVID-19%20Vaccine%22%20OR%20%22mRNA-1273%20SARS-CoV-2%22\">Advisories</a>",
				"various_dates": "Yes"
			},
			{
				"id": "63",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-12-23T12:00:00Z\">Wed, 12/23/2020 - 12:00</time>\n",
				"description": "<p>The steps to Moderna COVID-19 Vaccination. Your guide to proper storage, handling, and administration for the Moderna COVID-19 Vaccine.</p>\n",
				"resource_link": "<a href=\"/info/pdf/moderna-covid-19-vaccine-storage-handling.pdf\">Storage, handling, and administration</a>",
				"various_dates": "No"
			}
		]
	},
	{
		"nid": "14",
		"title": "JNJ-78436735/Ad26.COV2.S",
		"brand_name": "JNJ-78436735/Ad26.COV2.S",
		"company_name": "Janssen Inc",
		"ingredient": "Ad26.COV2.S",
		"status": "Under review",
		"date_of_approval": null,
		"language": "English",
		"body_text": null,
		"resources": []
	},
	{
		"nid": "13",
		"title": "AstraZeneca COVID-19 Vaccine (ChAdOx1-S)",
		"brand_name": "AstraZeneca COVID-19 Vaccine",
		"company_name": "AstraZeneca Canada Inc",
		"ingredient": "ChAdOx1-S",
		"status": "Under review",
		"date_of_approval": null,
		"language": "English",
		"body_text": null,
		"resources": [
			{
				"id": "79",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals",
					"Researchers"
				],
				"description": "<p>TBD</p>\n",
				"resource_link": "<span>test</span>",
				"various_dates": "No"
			}
		]
	},
	{
		"nid": "9",
		"title": "Veklury (remdesivir)",
		"brand_name": "Veklury",
		"company_name": "Gilead Sciences Canada Inc",
		"ingredient": "remdesivir",
		"status": "Authorized",
		"date_of_approval": "<time datetime=\"2020-07-27T12:00:00Z\">Mon, 07/27/2020 - 12:00</time>\n",
		"language": "English",
		"body_text": "<h2>More information</h2>\n\n<ul>\n\t<li><a href=\"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/treatments/remdesivir.html\">What you should know</a></li>\n\t<li><a href=\"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/treatments/remdesivir/authorization.html\">Authorization information</a></li>\n\t<li><a href=\"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/treatments/remdesivir/monitoring.html\">Continued monitoring</a></li>\n</ul>\n",
		"resources": [
			{
				"id": "5",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2021-02-11T12:00:00Z\">Thu, 02/11/2021 - 12:00</time>\n",
				"description": "<p>Information about the product including what the product is used for, dosage, warnings, proper use and side effects.  This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.</p>\n",
				"resource_link": "<a href=\"/info/veklury-en.html\">Consumer Information</a>",
				"various_dates": "No"
			},
			{
				"id": "6",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-07-27T12:00:00Z\">Mon, 07/27/2020 - 12:00</time>\n",
				"description": "<p>The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use.</p>\n\n<p>The Product Monograph includes three sections:</p>\n\n<ul>\n\t<li>Part I: Health Professional Information;</li>\n\t<li>Part II: Scientific Information; and</li>\n\t<li>Patient Medication Information</li>\n</ul>\n\n<p> </p>\n",
				"resource_link": "<a href=\"/info/pdf/veklury-pm1-en.pdf\">Product Monograph</a>",
				"various_dates": "No"
			},
			{
				"id": "8",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers"
				],
				"date": "<time datetime=\"2020-07-27T12:00:00Z\">Mon, 07/27/2020 - 12:00</time>\n",
				"description": "<p>The Regulatory Decision Summary explains Health Canada’s decision for the product seeking market authorization. The RDS includes the purpose of the submission and the reason for the decision.</p>\n",
				"resource_link": "<a href=\"/info/regulatory-decision-summary-detail.html?linkID=RDS00669\">Regulatory Decision Summary</a>",
				"various_dates": "No"
			},
			{
				"id": "14",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-02T12:00:00Z\">Wed, 12/02/2020 - 12:00</time>\n",
				"description": "<p>The Summary Basis of Decision explains why the product was approved for sale in Canada. The document includes regulatory, safety, effectiveness and quality (in terms of chemistry and manufacturing) considerations.</p>\n",
				"resource_link": "<a href=\"/info/summary-basis-decision-detailTwo.html?linkID=SBD00491\">Summary Basis of Decision</a>",
				"various_dates": "No"
			},
			{
				"id": "72",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-01-26T13:00:00Z\">Tue, 01/26/2021 - 13:00</time>\n",
				"description": "<p>The Post Authorization Activity Table includes brief summaries of the activities that occur after the approval of the product. It is updated on a monthly basis.</p>\n",
				"resource_link": "<a href=\"/info/post-authorization-activity-table.html?linkID=SBD00491\">Post-Authorization Activity Table (PAAT) </a>",
				"various_dates": "No"
			},
			{
				"id": "10",
				"bundle": "vaccine_resources",
				"audience": [
					"Researchers"
				],
				"date": "<time datetime=\"2020-10-30T12:00:00Z\">Fri, 10/30/2020 - 12:00</time>\n",
				"description": "<p>After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.</p>\n",
				"resource_link": "<a href=\"https://clinical-information.canada.ca/ci-rc/terms?id=240551\">Clinical Information</a>",
				"various_dates": "No"
			},
			{
				"id": "15",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-07-27T12:00:00Z\">Mon, 07/27/2020 - 12:00</time>\n",
				"description": "<p>For COVID-19 authorizations, Health Canada can impose specific terms and conditions on the authorization. This allows Health Canada to continue to gather information on the safety, effectiveness and/or quality of the product as more studies are completed.</p>\n",
				"resource_link": "<a href=\"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-veklury-240551.html\">Authorization Terms &amp; Conditions</a>",
				"various_dates": "No"
			},
			{
				"id": "7",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"description": "<p>Advisories are published when Health Canada has important updates or other information to share about the product, such as information on new approvals, shortages, labelling updates, or risks.</p>\n\n<p>Clicking the link will retrieve any advisories Health Canada has issued about the product. If no advisories have been issued, no results will be returned.</p>\n",
				"resource_link": "<a href=\"https://healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/result-resultat/en?search_text_1=Remdesivir%20OR%20Veklury\">Advisories</a>",
				"various_dates": "Yes"
			},
			{
				"id": "13",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-11-26T12:00:00Z\">Thu, 11/26/2020 - 12:00</time>\n",
				"description": "<p>An update from Health Canada on the continued monitoring of the use of remdesivir for COVID-19.</p>\n",
				"resource_link": "<a href=\"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/remdesivir-update.html\">Update on remdesivir: continued monitoring</a>",
				"various_dates": "No"
			}
		]
	},
	{
		"nid": "8",
		"title": "Bamlanivimab (bamlanivimab)",
		"brand_name": "Bamlanivimab",
		"company_name": "Eli Lilly Canada Inc",
		"ingredient": "bamlanivimab",
		"status": "Authorized By Interim Order",
		"date_of_approval": "<time datetime=\"2020-11-20T12:00:00Z\">Fri, 11/20/2020 - 12:00</time>\n",
		"language": "English",
		"body_text": null,
		"resources": [
			{
				"id": "17",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"date": "<time datetime=\"2020-11-20T12:00:00Z\">Fri, 11/20/2020 - 12:00</time>\n",
				"description": "<p>Information about the product including what the product is used for, dosage, warnings, proper use and side effects.  This summary will not tell you everything about the drug. Contact your healthcare professional if you have any questions about the product.</p>\n",
				"resource_link": "<a href=\"/info/bamlanivimab-en.html\">Consumer Information</a>",
				"various_dates": "No"
			},
			{
				"id": "18",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-11-20T12:00:00Z\">Fri, 11/20/2020 - 12:00</time>\n",
				"description": "<p>The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use.</p>\n\n<p>The Product Monograph includes three sections:</p>\n\n<ul>\n\t<li>Part I: Health Professional Information;</li>\n\t<li>Part II: Scientific Information; and</li>\n\t<li>Patient Medication Information</li>\n</ul>\n\n<p> </p>\n",
				"resource_link": "<a href=\"/info/pdf/bamlanivimab-pm1-en.pdf\">Product Monograph</a>",
				"various_dates": "No"
			},
			{
				"id": "19",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers"
				],
				"date": "<time datetime=\"2020-10-12T12:00:00Z\">Mon, 10/12/2020 - 12:00</time>\n",
				"description": "<p>The Regulatory Decision Summary explains Health Canada’s decision for the product seeking market authorization. The RDS includes the purpose of the submission and the reason for the decision.</p>\n",
				"resource_link": "<a href=\"/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00719\">Regulatory Decision Summary</a>",
				"various_dates": "No"
			},
			{
				"id": "20",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-01-08T16:00:00Z\">Fri, 01/08/2021 - 16:00</time>\n",
				"description": "<p>The Summary Basis of Decision explains why the product was approved for sale in Canada. The document includes regulatory, safety, effectiveness and quality (in terms of chemistry and manufacturing) considerations.</p>\n",
				"resource_link": "<a href=\"/info/summary-basis-decision-detailTwo.html?linkID=SBD00512\">Summary Basis of Decision</a>",
				"various_dates": "No"
			},
			{
				"id": "71",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2021-02-05T14:00:00Z\">Fri, 02/05/2021 - 14:00</time>\n",
				"description": "<p>The Post Authorization Activity Table includes brief summaries of the activities that occur after the approval of the product. It is updated on a monthly basis.</p>\n",
				"resource_link": "<a href=\"/info/post-authorization-activity-table.html?linkID=SBD00512\">Post-Authorization Activity Table (PAAT) </a>",
				"various_dates": "No"
			},
			{
				"id": "21",
				"bundle": "vaccine_resources",
				"audience": [
					"Researchers"
				],
				"date": "<time datetime=\"2021-01-04T12:00:00Z\">Mon, 01/04/2021 - 12:00</time>\n",
				"description": "<p>After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.</p>\n",
				"resource_link": "<a href=\"https://clinical-information.canada.ca/ci-rc/terms?id=244947\">Clinical Information</a>",
				"various_dates": "No"
			},
			{
				"id": "22",
				"bundle": "vaccine_resources",
				"audience": [
					"Health Care Professionals",
					"Researchers"
				],
				"date": "<time datetime=\"2020-12-23T10:00:00Z\">Wed, 12/23/2020 - 10:00</time>\n",
				"description": "<p>For COVID-19 authorizations, Health Canada can impose specific terms and conditions on the authorization. This allows Health Canada to continue to gather information on the safety, effectiveness and/or quality of the product as more studies are completed.</p>\n",
				"resource_link": "<a href=\"/info/pdf/bamlanivimab-authorisation.pdf\">Authorization Terms &amp; Conditions</a>",
				"various_dates": "No"
			},
			{
				"id": "23",
				"bundle": "vaccine_resources",
				"audience": [
					"Consumers",
					"Health Care Professionals"
				],
				"description": "<p>Advisories are published when Health Canada has important updates or other information to share about the product, such as information on new approvals, shortages, labelling updates, or risks.</p>\n\n<p>Clicking the link will retrieve any advisories Health Canada has issued about the product. If no advisories have been issued, no results will be returned.</p>\n\n<p> </p>\n",
				"resource_link": "<a href=\"https://healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/result-resultat/en?search_text_1=Bamlanivimab%20OR%20bamlanivimab\">Advisories</a>",
				"various_dates": "Yes"
			}
		]
	}
]